These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37424088)

  • 21. Fentanyl sublingual spray for breakthrough pain in cancer patients.
    Zeppetella G
    Pain Ther; 2013 Jun; 2(1):1-9. PubMed ID: 25135032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain.
    Devulder J; Jacobs A; Richarz U; Wiggett H
    Br J Anaesth; 2009 Oct; 103(4):576-85. PubMed ID: 19736216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study.
    Villarroel PG; Padró JG; Marquina G; Jáñez NM; González EE; Antón A; Sánchez MB; Cáceres AR; López-López R; Cornejo RE; García PB; Fabregat RM; Fernández BC; Bermudo CL; Camps C
    Future Oncol; 2022 Nov; 18(35):3913-3927. PubMed ID: 36537885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxycodone/Acetaminophen: The Tailoring Combination Treatment for Specific Clinical Profile of Opioid Well-Responsive Cancer Pain.
    De Santis S; Simone MD; Mercadante S; Mediati RD; Vellucci R; Marchetti P; Tonini G; Cuomo A; Caraceni A; Natoli S; Armento G; Blasi L; Mammucari M;
    Cancer Manag Res; 2021; 13():1747-1756. PubMed ID: 33642876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating breakthrough pain in oncology.
    Mercadante S
    Expert Rev Anticancer Ther; 2018 May; 18(5):445-449. PubMed ID: 29478355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.
    Mystakidou K; Katsouda E; Parpa E; Tsiatas ML; Vlahos L
    J Opioid Manag; 2005; 1(1):36-40. PubMed ID: 17315410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of breakthrough pain in children with cancer.
    Friedrichsdorf SJ; Postier A
    J Pain Res; 2014; 7():117-23. PubMed ID: 24639603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of rapid onset fentanyl products in the management of breakthrough pain in cancer patients.
    Brząkała J; Leppert W
    Pharmacol Rep; 2019 Jun; 71(3):438-442. PubMed ID: 31003154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current management of breakthrough cancer pain according to physicians from pain units in Spain.
    Estévez FV; Alarcón MDL; Mayoral V; de Madariaga M; Margarit C; Duran JA; Martín-Arroyo JMT; Carregal A;
    Clin Transl Oncol; 2019 Sep; 21(9):1168-1176. PubMed ID: 30783918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of breakthrough cancer pain].
    Sláma O
    Klin Onkol; 2013; 26(3):191-4. PubMed ID: 23763322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.
    Mystakidou K; Katsouda E; Parpa E; Tsiatas ML; Vlahos L
    Am J Hosp Palliat Care; 2005; 22(3):228-32. PubMed ID: 15909786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain.
    Prommer E; Ficek B
    Patient Prefer Adherence; 2012; 6():465-75. PubMed ID: 22791984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fixed inhaled nitrous oxide/oxygen mixture as an analgesic for adult cancer patients with breakthrough pain: study protocol for a randomized controlled trial.
    Liu Q; Wang Y; Luo XJ; Wang NJ; Chen P; Jin X; Mu GX; Chai XM; Zhang YJ; Li YX; Yu JQ
    Trials; 2017 Jan; 18(1):13. PubMed ID: 28077162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
    Mercadante S; Caraceni A; Masedu F; Scipioni T; Aielli F
    Oncologist; 2020 Feb; 25(2):156-160. PubMed ID: 31862860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fentanyl buccal tablet.
    Messina J; Darwish M; Fine PG
    Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breakthrough pain in cancer patients.
    Zeppetella G
    Clin Oncol (R Coll Radiol); 2011 Aug; 23(6):393-8. PubMed ID: 21227666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy for breakthrough cancer pain.
    Mercadante S
    Drugs; 2012 Jan; 72(2):181-90. PubMed ID: 22233484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of breakthrough pain vs. pharmacokinetics of oral morphine: implications for management.
    Zeppetella G
    Eur J Cancer Care (Engl); 2009 Jul; 18(4):331-7. PubMed ID: 19473378
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.